Skip to main content

Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population


Although mefloquine is the only drug licensed for malaria chemoprophylaxis in Japan, there have been few reports describing the effects of and adverse events in the prophylactic usage of mefloquine in a Japanese population. We therefore performed a questionnaire-based study in 21 travelers who were prescribed mefloquine for malaria chemoprophylaxis between October 2001 and December 2003. The study revealed that only 8 out of 21 (38.1%) of the travelers could complete the prophylaxis schedules. Another 8 travelers (38.1%) with incomplete adherence stated that they did not take mefloquine because of either actually experienced or anticipated adverse events. Twelve of the 16 travelers (75.0%) who took mefloquine complained of at least one adverse event probably related to mefloquine. As an overall impression about mefloquine chemoprophylaxis, 14 of the 21 travelers stated that they would take mefloquine again for the next travel to malaria-endemic areas, although 5 of them were concerned about adverse events. These results suggest that, although mefloquine is an indispensable drug for malaria prevention, other effective and well-tolerated chemoprophylactic antimalarials should be available for Japanese travelers who do not tolerate mefloquine.

This is a preview of subscription content, access via your institution.


  1. S Kano M Kimura (2004) ArticleTitleTrends in malaria cases in Japan Acta Trop 89 271–8 Occurrence Handle10.1016/j.actatropica.2003.10.003 Occurrence Handle14744553

    Article  PubMed  Google Scholar 

  2. M Kimura A Suzaki Y Matsumoto K Nakajima Y Wataya H Ohtomo (2003) ArticleTitleEpidemiological and clinical aspects of malaria inJapan J Travel Med 10 122–7 Occurrence Handle12650657

    PubMed  Google Scholar 

  3. H Ohtomo T Takeuchi (1998) ArticleTitleStudies on current trend of imported malaria in Japan Nippon Nettai Igakkai Zasshi 26 151–6

    Google Scholar 

  4. AM Croft P Garner (1997) ArticleTitleMefloquine to prevent malaria: a systemic review of trials BMJ 315 1412–6 Occurrence Handle9418088

    PubMed  Google Scholar 

  5. E Wooltorton (2002) ArticleTitleMefloquine: contraindicated in patients with mood, psychotic or seizure disorders Can Med Assoc J 167 1147

    Google Scholar 

  6. S Takeshima (1994) ArticleTitleSide effects with mefloquine for long-term malaria prophylaxis Nippon Nettai Igakkai Zasshi 22 185–92

    Google Scholar 

  7. T Suginuma S Terada K Ieda A Tsuji S Miyamori (1994) ArticleTitleSide effects of mefloquine, an antimalarial agent, observed during its chemoprophylactic administration Boei Eisei 41 49–55

    Google Scholar 

  8. D Overbosch H Schilthuis U Bienzle RH Behrens KC Kain PD Clarke et al. (2001) ArticleTitleAtvaquone-Proguanil versus mefloquine formalaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study Clin Infect Dis 33 1015–21 Occurrence Handle10.1086/322694 Occurrence Handle11528574

    Article  PubMed  Google Scholar 

  9. PJ Barrett PD Emmins PD Clarke DJ Bradley (1996) ArticleTitleComparison of adverse effects associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers BMJ 313 525–8 Occurrence Handle8789977

    PubMed  Google Scholar 

  10. AM Croft A Herxheimer (2002) ArticleTitleAdverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? BMC Public Health 2 6–13 Occurrence Handle10.1186/1471-2458-2-6 Occurrence Handle11914150

    Article  PubMed  Google Scholar 

  11. P Schlagenhauf A Tschopp R Johnson HD Nothdurft B Beck E Schwartz et al. (2003) ArticleTitleTolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: multicentre, randomized, double blind, four arm study BMJ 327 1078–84 Occurrence Handle10.1136/bmj.327.7423.1078 Occurrence Handle14604928

    Article  PubMed  Google Scholar 

  12. D Bradley B Bannister (2003) ArticleTitleGuidelines for malaria prevention in travelers from the United Kingdom for 2003 Commun Dis Public Health 6 180–99 Occurrence Handle14708268

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Tetsuya Nakamura.

About this article

Cite this article

Matsumura, T., Fujii, T., Miura, T. et al. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population. J Infect Chemother 11, 196–198 (2005).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

Key words

  • Malaria
  • Mefloquine
  • Chemoprophylaxis
  • Travel medicine
  • Adverse effect
  • Adherence